Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a


Nu se va prescrie în regim compensat pentru tratamentul litiazei biliare



Yüklə 4,39 Mb.
səhifə366/381
tarix07.01.2022
ölçüsü4,39 Mb.
#80899
1   ...   362   363   364   365   366   367   368   369   ...   381
Nu se va prescrie în regim compensat pentru tratamentul litiazei biliare.
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

A05AA02 ACIDUM CAPS. 250 mg

URSODEOXYCHOLICUM

URSOFALK(R) 250 mg DR. FALK PHARMA GMBH

URSOSAN 250 mg PRO. MED. CS PRAHA AS

________________________________________________________________________________


#M4

______________________________________________________________________________

| 1017 | *** Abrogată |

|_______|______________________________________________________________________|
______________________________________________________________________________

| 1018 | *** Abrogată |

|_______|______________________________________________________________________|
______________________________________________________________________________

| 1019 | *** Abrogată |

|_______|______________________________________________________________________|
#B

______________________________________________________________________________

| 1021 |H02AB04| METHYLPREDNISOLONUM | |

|_______|_______|____________________________________________|_________________|


________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 125 mg

LEMOD SOLU 125 mg 125 mg HEMOFARM S.R.L.
H02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV. PT. SOL. 125 mg/2 ml

INJ.


SOLU-MEDROL ACT-O-VIAL 125 mg/2 ml PFIZER EUROPE MA EEIG
H02AB04 METHYLPREDNISOLONUM COMPR. 16 mg

MEDROL A 16 16 mg PFIZER EUROPE MA EEIG


H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 20 mg

LEMOD SOLU 20 mg 20 mg HEMOFARM S.R.L.


H02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV. PT. SOL. 250 mg/4 ml

INJ.


SOLU-MEDROL ACT-O-VIAL 250 mg/4 ml PFIZER EUROPE MA EEIG
H02AB04 METHYLPREDNISOLONUM COMPR. 32 mg

MEDROL 32 32 mg PFIZER EUROPE MA EEIG


H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 40 mg

LEMOD SOLU 40 mg 40 mg HEMOFARM S.R.L.


H02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV. PT. SOL. 40 mg/1 ml

INJ.


SOLU-MEDROL ACT-O-VIAL 40 mg/1 ml PFIZER EUROPE MA EEIG
H02AB04 METHYLPREDNISOLONUM COMPR. 4 mg

MEDROL 4 mg 4 mg PFIZER EUROPE MA EEIG


H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 500 mg

LEMOD SOLU 500 mg 500 mg HEMOFARM S.R.L.


H02AB04 METHYLPREDNISOLONUM LIOF. + SOLV. PT. SOL. 500 mg/7.8 ml

INJ.


SOLU-MEDROL 500 mg/7,8 ml 500 mg/7.8 ml PFIZER EUROPE MA EEIG

________________________________________________________________________________


______________________________________________________________________________

| 1022 |H02AB07| PREDNISONUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

H02AB07 PREDNISONUM COMPR. 5 mg

N-PREDNISON 5 mg MEDUMAN SA

PREDNISON 5 mg 5 mg SINTOFARM SA

PREDNISON ARENA 5 mg 5 mg ARENA GROUP SA

PREDNISON GEDEON RICHTER 5 mg 5 mg GEDEON RICHTER ROMANIA SA

PREDNISON MAGISTRA 5 mg 5 mg MAGISTRA C & C

________________________________________________________________________________


______________________________________________________________________________

| 1023 |J01EE01| SULFAMETHOXAZOLUM + TRIMETHOPRIMUM | |

|_______|_______|____________________________________________|_________________|
Există un risc crescut de reacţie adversă severă la administrarea acestui medicament la persoane în vârstă.


Yüklə 4,39 Mb.

Dostları ilə paylaş:
1   ...   362   363   364   365   366   367   368   369   ...   381




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©muhaz.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin